FR2292475B1 - - Google Patents
Info
- Publication number
- FR2292475B1 FR2292475B1 FR7535898A FR7535898A FR2292475B1 FR 2292475 B1 FR2292475 B1 FR 2292475B1 FR 7535898 A FR7535898 A FR 7535898A FR 7535898 A FR7535898 A FR 7535898A FR 2292475 B1 FR2292475 B1 FR 2292475B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU74RI00000555A HU171165B (hu) | 1974-11-26 | 1974-11-26 | Sposob poluchenija proizvodnykh oktagidro-indolo-skobka-2,3-a-skobka zakryta-kinolizina |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2292475A1 FR2292475A1 (fr) | 1976-06-25 |
| FR2292475B1 true FR2292475B1 (US20030157376A1-20030821-M00001.png) | 1979-06-29 |
Family
ID=11000966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7535898A Granted FR2292475A1 (fr) | 1974-11-26 | 1975-11-25 | Composes polycycliques azotes nouveaux, leur procede de preparation et leur application pharmacologique |
Country Status (20)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA786426B (en) * | 1977-11-25 | 1979-10-31 | Scras | New indulo(2,3-a)quinolizidines,preparation and therapeutic use |
| HU178700B (en) * | 1978-02-10 | 1982-06-28 | Richter Gedeon Vegyeszet | Process for preparing 1,1-disubstituted octahydro-indolo/2,3-a/-quinolizines |
| US4353911A (en) * | 1979-07-20 | 1982-10-12 | Andre Buzas | Indolo(2,3-a)quinolizidines, useful in increasing femoral and vertebral blood flow |
| US4358452A (en) * | 1980-05-09 | 1982-11-09 | John Wyeth & Brother Limited | N-[1,2,3,4,6,7,12,12 α-octahydro-2H-indolo(2,3α)-quinolizinyl-2β-yl]alkane and benzyl sulfonamides and anti-hypertensive use thereof |
| DE3320364C2 (de) * | 1983-06-06 | 1986-11-13 | Henke-Sass, Wolf Gmbh, 7200 Tuttlingen | Injektionsspritze |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3454583A (en) * | 1965-07-19 | 1969-07-08 | Us Health Education & Welfare | Synthesis of vincamine |
| US3536725A (en) * | 1967-11-22 | 1970-10-27 | Miles Lab | Cyanoethylated derivatives of 2,3,4,6,7,12-hexahydroindolo(2,3-alpha)-quinolizine |
| HU163143B (US20030157376A1-20030821-M00001.png) * | 1971-05-07 | 1973-06-28 | ||
| FR2179620B1 (US20030157376A1-20030821-M00001.png) * | 1972-04-14 | 1975-12-26 | Roussel Uclaf | |
| FR2190113A5 (US20030157376A1-20030821-M00001.png) * | 1972-06-19 | 1974-01-25 | Anvar | |
| GB1435573A (en) * | 1973-05-25 | 1976-05-12 | Wyeth John & Brother Ltd | Indoloquinolizines |
-
1974
- 1974-11-26 HU HU74RI00000555A patent/HU171165B/hu not_active IP Right Cessation
-
1975
- 1975-11-18 CH CH1502575A patent/CH624954A5/de not_active IP Right Cessation
- 1975-11-19 IL IL48495A patent/IL48495A/xx unknown
- 1975-11-19 DE DE2551952A patent/DE2551952C3/de not_active Expired
- 1975-11-21 CS CS757916A patent/CS228102B2/cs unknown
- 1975-11-21 SE SE7513126A patent/SE423901B/xx not_active IP Right Cessation
- 1975-11-24 DD DD189640A patent/DD123751A5/xx unknown
- 1975-11-24 AT AT890675A patent/AT349021B/de not_active IP Right Cessation
- 1975-11-25 FR FR7535898A patent/FR2292475A1/fr active Granted
- 1975-11-25 PL PL1975185006A patent/PL101823B1/pl unknown
- 1975-11-25 DK DK529875AA patent/DK139432B/da not_active IP Right Cessation
- 1975-11-25 BE BE162153A patent/BE835913A/xx not_active IP Right Cessation
- 1975-11-25 BG BG031572A patent/BG25225A3/xx unknown
- 1975-11-25 CA CA240,411A patent/CA1071628A/en not_active Expired
- 1975-11-25 US US05/635,092 patent/US4052404A/en not_active Expired - Lifetime
- 1975-11-25 NL NL7513725A patent/NL7513725A/xx not_active Application Discontinuation
- 1975-11-26 JP JP50141542A patent/JPS5910359B2/ja not_active Expired
- 1975-11-26 SU SU752194151A patent/SU629878A3/ru active
- 1975-11-26 GB GB48558/75A patent/GB1518696A/en not_active Expired
- 1975-11-26 YU YU2992/75A patent/YU39338B/xx unknown
-
1976
- 1976-09-01 SU SU762391603A patent/SU657749A3/ru active
Also Published As
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |